Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
Publ. Version/Full Text
DOI
 |
Open Access Gold (Paid Option) |
|
as soon as is submitted to ZB.
Advances in the molecular etiology of severe combined immunodeficiency and its screening.
Turk. J. Immunol. 11, 1-16 (2023)
Severe combined immunodeficiency (SCID) is the most severe heterogeneous group of inherited disorders characterized by profound abnormalities such as humoral and cell-mediated immunity defects and hindered natural killer cell development and function. The knowledge of the molecular basis of SCID is essential for precise diagnosis and early treatment. In recent years, new genetic defects that cause SCID have been discovered, and the molecular and immunological mechanisms of SCID have been better understood. SCID symptoms include candidiasis, chronic diarrhea, failure to grow, and oral thrush. Hematopoietic stem cell transplantation, enzyme replacement therapy, and gene therapy are used to treat SCID. The prevalence of SCID varies worldwide. More than 80% of SCID infants have no family history of the condition. However, the development of a newborn screening test has enabled SCID detection before symptoms appear, ensuring that affected infants receive life-saving treatments. Countries that organize newborn screening programs for SCID can detect patients in their early stages of life and treat them accordingly. This review will serve as a source of up-to-date information on the identification of various genetic disorders that cause SCID, as well as their clinical characteristics, treatments, and diagnosis options, potentially saving the lives of many infants before pathogenic infections occur.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Review
Keywords
Diagnosis ; Immunodeficiency ; Severe Combined Immunodeficiency ; Therapeutics; Interleukin-2-receptor Gamma-chain; T-cell Lymphopenia; B Plus Nk; Adenosine-deaminase; Omenn Syndrome; Gene-therapy; Hematopoietic Stem; Receptor Gene; Deficiency; Mutations
ISSN (print) / ISBN
1301-109X
e-ISSN
2147-8325
Journal
Turkish Journal of Immunology
Quellenangaben
Volume: 11,
Issue: 1,
Pages: 1-16
Publisher
Turkish Society of Immunology
Publishing Place
Kacamak Sokak 21/1, Istanbul, Findikzade, Turkey
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Lung Health and Immunity (LHI)